2Leung YM, Ahmed I, Sheu L, et al. Insulin regulates islet a-cell function by reducing KATP channel sensitivity to adenosine 5'-triphosphate inhibition [J]. Endocrinology, 2006, 147(5): 2155-2162.
3Xu E, Kumar M, Zhang Y, et al. Intra-islet insulin sup- presses glucagon release via GABA-GABAA receptor sys- tem[J]. Cell Metab, 2006, 3(1): 47-58.
4Ravier MA, Rutter GA. Glucose or insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic α- cells[J]. Diabetes, 2005, 54(6): 1789-1797.
6Zamaklar M, Jotic A, Lalic N, et al. Relation between course of disease in type 1 diabetes and islet cell anti- bodies[J]. Ann N Y Acad Sci, 2002, 958: 251-253.
8Larsson H, Ahren B. Islet dysfunction in insulin resis- tance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with im- paired glucose tolerance [J]. Diabetes Care, 2000, 23(5): 650-657.
10Aiaujo ER, Amaral ME, Souza CT, et al. Blockade of IRS-1 in isolated rat pancreatic islets improves glucose-induced insulin secretion. FEBS Lett, 2002,531:437-432.
1Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised triM. Lancet, 2002, 35(9):2072-2077.
2Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Diabetic Medicine, 2008, 25(10):1151-1156.
3Sartore G, Chilelli NC, Burlina S, et al. The importance of HbAlc and glucose variability in patients with type 1 and type 2 diabetes:outcome of continuous glucose monitoring (CGM).Acta Diabetol, 2012, 49(1):153-160.
4Ahrm B, Schweizer A, Dejager S, et al. Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes.J Clin Endocrinol Metab, 2009, 94(4):1236-1243.
5Raffaele Marfella, Michelangel Barbieria, Rodolfo Grella, et al. Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations.Journal of Diabetes and Its Complications, 2010, 24(2):79-83.
6Buteau J. GLP-1 receptor signaling: effects on pancreatic betacell proliferation and surviva. Diabetes Metab, 2008, 34(Suppl 2):73-77.
7Holst JJ. The physiology of glucagon-like peptide 1.Physiol Rev, 2007, 87(4):1409-1439.
8Sandoval D. CNS GLP-1 regulation of peripheral glucose homeostasis.Physiol Behav, 2008, 94(5):670-674.
9Gang Xu, Stoffers DA, Habener JF, et el. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta- cell mass and improved glucose tolerance in diabetic rats.Diabete, 1999, 48(2):2270-2276.
10MoriY, ehi Y, Matsuura K, et el. Effects of sitagliptin on 24-h glyc emic changes in Japanese patients with type 2 diabetes assessed u sing continuous glucose monitoring.Diabetes Technol Ther, 2011, 13(7):699-703.
